Value Bridge — JOHNS HOPKINS ALL CHILDRENS HOSPITA
Current $-60M → Target $-47M (+$12.9M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-60.1M
Current EBITDA
$-47.2M
Target EBITDA
+$12.9M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.9M
Payer Mix Optimization
$7.0M
Cost to Collect Reduction
$2.3M
Clean Claim Improvement
$1.8M
Volume & Rate Growth
$11.7M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-60M to $-47M. The highest-impact lever is Volume & Rate Growth at $4.7M probability-weighted.
IC talking point: "We see $13M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $142M in equity value creation."